


<!DOCTYPE html>
<html lang="en">
<head><script src="//archive.org/includes/analytics.js?v=cf34f82" type="text/javascript"></script>
<script type="text/javascript">window.addEventListener('DOMContentLoaded',function(){var v=archive_analytics.values;v.service='wb';v.server_name='wwwb-app39.us.archive.org';v.server_ms=498;archive_analytics.send_pageview({});});</script><script type="text/javascript" src="/static/js/wbhack.js?v=1531166943.0" charset="utf-8"></script>

<script type="text/javascript">
__wbhack.init('https://web.archive.org/web');
</script>
<link rel="stylesheet" type="text/css" href="/static/css/banner-styles.css?v=1531166943.0" />
<link rel="stylesheet" type="text/css" href="/static/css/iconochive.css?v=1531166943.0" />

<!-- End Wayback Rewrite JS Include -->  

        <title>Occupational therapy practice guidelines for adults with neurodegenerative diseases. | National Guideline Clearinghouse</title>

    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width">
    <link rel="icon" href="/web/20180712210301im_/https://www.guideline.gov/UI/images/favicon-NGC.ico">
    <link rel="apple-touch-icon" sizes="180x180" href="/web/20180712210301im_/https://www.guideline.gov/UI/images/apple-touch-icon-NGC.png">
    <link rel="icon" type="image/png" href="/web/20180712210301im_/https://www.guideline.gov/UI/images/favicon-NGC-32x32.png" sizes="32x32">
    <link rel="icon" type="image/png" href="/web/20180712210301im_/https://www.guideline.gov/UI/images/favicon-NGC-16x16.png" sizes="16x16">
    <link rel="manifest" href="/web/20180712210301/https://www.guideline.gov/UI/images/manifest-NGC.json">
    <link rel="mask-icon" href="/web/20180712210301im_/https://www.guideline.gov/UI/images/safari-pinned-tab-NGC.svg" color="#1d4345">
    <meta name="theme-color" content="#ffffff">
    
<link href="/web/20180712210301cs_/https://www.guideline.gov/cassette.axd/stylesheet/8382974d7bae1577062376dcd37102348398fe04/NGCSiteCSS" type="text/css" rel="stylesheet"/>
<!--[if lt IE 9]>
<link href="/cassette.axd/stylesheet/2188ac5b8507764bb4079068f7a3c8d7ccfba0e7/ieCSS" type="text/css" rel="stylesheet"/>
<![endif]-->



    <script async type="text/javascript" id="_fed_an_ua_tag" src="https://web.archive.org/web/20180712210301js_/https://dap.digitalgov.gov/Universal­-Federated-­Analytics-­Min.js?agency=HHS&amp;subagency=AHRQ"></script>
    </head>
<body class="no-js content-page">
<a href="#main-content" id="skip-nav">Skip to main content</a>
<!--https://developers.google.com/tag-manager/devguide#multidomain  ECH-1199-->
    
    <!-- Google Tag Manager -->
    <noscript>
        <iframe src="//web.archive.org/web/20180712210301if_/https://www.googletagmanager.com/ns.html?id=GTM-W4NX5V" height="0" width="0" style="display:none;visibility:hidden"></iframe>
    </noscript>
    <script>
        (function (w, d, s, l, i) {
            w[l] = w[l] || []; w[l].push({
                'gtm.start':
                new Date().getTime(), event: 'gtm.js'
            }); var f = d.getElementsByTagName(s)[0],
            j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src =
            '//web.archive.org/web/20180712210301/https://www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f);
        })(window, document, 'script', 'dataLayer', 'GTM-W4NX5V');</script>

    <noscript>
        <iframe src="//web.archive.org/web/20180712210301if_/https://www.googletagmanager.com/ns.html?id=GTM-KHDP6Z" height="0" width="0" style="display:none;visibility:hidden"></iframe>
    </noscript>
    <script>
        (function (w, d, s, l, i) {
            w[l] = w[l] || []; w[l].push({
                'gtm.start':
                new Date().getTime(), event: 'gtm.js'
            }); var f = d.getElementsByTagName(s)[0],
            j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src =
            '//web.archive.org/web/20180712210301/https://www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f);
        })(window, document, 'script', 'dataLayer', 'GTM-KHDP6Z');</script>
    <!-- End Google Tag Manager -->


    <!-- AHRQ HEADER -->
<div id="ahrq-header">

	<p class="hhs-links">
		<a href="https://web.archive.org/web/20180712210301/http://www.hhs.gov/" target="_blank" class="logo-hhs"><span class="logomark"></span>U.S.&nbsp;Department of&nbsp;Health&nbsp;and Human&nbsp;Services</a>
		<a href="https://web.archive.org/web/20180712210301/http://www.hhs.gov/" target="_blank" class="external-link"><strong>HHS.gov</strong></a>
	</p><!-- /.hhs-links -->
	<p class="ahrq-links">
		<a href="https://web.archive.org/web/20180712210301/http://www.ahrq.gov/" target="_blank" class="logo-ahrq">Agency for Healthcare Research and Quality: Advancing Excellence in Health Care</a>
		<a href="https://web.archive.org/web/20180712210301/http://www.ahrq.gov/" target="_blank" class="external-link"><strong>AHRQ.gov</strong></a>
	</p><!-- /.ahrq-links -->

</div><!-- /#ahrq-header -->

	<!-- HEADER -->
	<div class="header" id="header">
		<div class="masthead">

			<ul class="header-actions">
				<li><a href="#header-search" class="search-action"><span class="label">Search</span></a></li>
				<li><a href="#header-account" class="account-action"><span class="label">Account</span></a></li>
				<li><a href="#main-nav" class="menu-action"><span class="label">Menu</span></a></li>
			</ul><!-- /.header-actions -->
				
				<a href="/web/20180712210301/https://www.guideline.gov/" class="header-logo NGC">
				    <picture>
				        <source media="(min-width: 960px)" srcset="/web/20180712210301im_/https://www.guideline.gov/UI/images/logo_NGC_header.png">
				        <source srcset="/web/20180712210301im_/https://www.guideline.gov/UI/images/logo_NGC_header_m.png">
				        <img src="/web/20180712210301im_/https://www.guideline.gov/UI/images/logo_NGC_header.png" alt="National Guideline Clearinghouse">
				    </picture>
				</a>
<form action="/web/20180712210301/https://www.guideline.gov/search" class="header-search header-action" enctype="multipart/form-data" id="header-search" method="get">					<p class="search-bar">
						<label for="q"><span class="screen-reader-text">Search</span>
							<input id="q" type="text" title="Search Input" name="q" class="search-input" placeholder="Search">
						</label>
						<input id="masthead-search-button" type="submit" title="Search Submit" class="search-submit" value="Search">
					</p>
					<p class="search-tips">
						<a href="/web/20180712210301/https://www.guideline.gov/help-and-about/search-browse/search-tips">Search Tips</a>
					</p>
</form>				<div class="header-account header-action" id="header-account">
				<a id="login-button" class="signin" href="/web/20180712210301/https://www.guideline.gov/accounts/signinlanding" aria-role="tab" aria-controls="login-panel" aria-selected="false">Log into My NGC</a>
<div id="login-panel" class="login dropdown" aria-role="tab-panel" aria-labeledby="login-button" aria-hidden="true">
    
            <div class="sign-in">
            <form id="sign-in-form" action="/web/20180712210301/https://www.guideline.gov/Accounts/LoginSubmit" method="post">
                <h3>Sign In</h3>
                <div class="errormessages"></div>
                <p class="invalid-user-cred message-block" style="display: none;"></p>
                <p>
                    <label for="sign-in-username">Username or Email <span class="required">*</span></label>
                    <input type="text" id="sign-in-username" class="input-text" name="email" required>
                   
                </p>
                <p>
                    <label for="sign-in-userpwd">Password <span class="required">*</span></label>
                    <input type="password" id="sign-in-userpwd" class="input-text" name="password" required>
                  
                </p>
                <p class="form-link"><a href="/web/20180712210301/https://www.guideline.gov/accounts/forgotpassword">Forgot Password?</a></p>
                <p><label for="remember-me"><input type="checkbox" name="remember-me" id="remember-me">Remember Me</label></p>
                <input id="account-sign-in" type="submit" value="Sign In"/>
            </form>
            <p>
                <label for="sign-up-btn">Don't have an account?</label>
                <a href="/web/20180712210301/https://www.guideline.gov/accounts/login" class="sign-up-btn" id="sign-up-btn">Create New Account</a>
            </p>
        </div><!--/.sign-in-->
</div><!-- /.login -->
				</div><!-- /.header-account -->
		</div><!-- /.masthead -->

		<div class="main-nav header-action" id="main-nav">
		    <ul class="level-1">
		        <li class=""><a href="/web/20180712210301/https://www.guideline.gov/">Home</a></li>
		        <li class=""><a href="/web/20180712210301/https://www.guideline.gov/new-this-week/index">New This Week</a></li>
		        <li>
<a href="/web/20180712210301/https://www.guideline.gov/summaries/browse" class="parent-link">Guideline Summaries</a>                    		            <ul class="level-2 dropdown">
                             <li class=""><a href="/web/20180712210301/https://www.guideline.gov/browse/clinical-specialty">By Clinical Specialty</a></li>
		                <li class=""><a href="/web/20180712210301/https://www.guideline.gov/browse/organization">By Organization</a></li>
		                <li class=""><a href="/web/20180712210301/https://www.guideline.gov/browse/mesh-tag">By MeSH Tag</a></li>
		                <li class=""><a href="/web/20180712210301/https://www.guideline.gov/summaries/in-progress">In Progress</a></li>
		                <li class=""><a href="/web/20180712210301/https://www.guideline.gov/summaries/archive">Archive</a></li>

		                <li class=""><a href="/web/20180712210301/https://www.guideline.gov/search?f_DocType=0&amp;fLockTerm=Guideline Summaries">All Summaries</a></li>
		            </ul>
		        </li>
<li class=""><a href="/web/20180712210301/https://www.guideline.gov/syntheses/index">Guideline Syntheses</a></li>		        <li class=""><a href="/web/20180712210301/https://www.guideline.gov/expert">Expert Commentaries</a></li>
		        <li class=""><a href="/web/20180712210301/https://www.guideline.gov/matrix">Matrix Tool</a></li>
		        <li class="">
<a href="/web/20180712210301/https://www.guideline.gov/summaries/submit">Submit Guidelines</a>                    		        </li>
                <li class=""><a href="/web/20180712210301/https://www.guideline.gov/help-and-about">Help &amp;&nbsp;About</a></li>		      
		    </ul>
		</div><!-- /.main-nav -->
</div><!-- /.header -->

    <br/><div class="content"><div class="fundingNotice2"><b>The AHRQ National Guideline Clearinghouse (NGC, guideline.gov) Web site will not be available after July 16, 2018</b> because federal funding <br/>through AHRQ will no longer be available to support the NGC as of that date. For additional information, read our <a href="/web/20180712210301/https://www.guideline.gov/home/announcements">full announcement</a>.</div></div>

	<!-- CONTENT -->
	<main id="main-content" tabindex="-1">
		

<div class="main">

		<div class="aside-container">

	<div class="content">

    <!-- CONTENT HEADER -->
    <div class="content-header">
        <ul class="content-header-meta">
            <li class="prefix-icon guideline">Guideline Summary</li>
            <li>NGC:010522</li>
            <li>2014
            </li>            
                                </ul>
        <div>
                <h1>Occupational therapy practice guidelines for adults with neurodegenerative diseases.</h1>
        </div>
    </div>
    <!-- /.content-header-meta -->

        <!-- CONTENT TABS -->
        <ul class="content-tabs">
            <li><a href="#developer-tab" class="developer is-active"><span class="label">Developer</span></a></li>
            <li><a href="#source-tab" class="source"><span class="label">Source</span></a></li>
            <li><a href="#status-tab" class="status"><span class="label">Status</span></a></li>
            <li><a href="#classification-tab" class="classification"><span class="label">Classification</span></a></li>
        </ul>
        <div id="developer-tab" class="is-active content-tab-panel">
                <ul class="developer-list">
        <li><a href="/web/20180712210301/https://www.guideline.gov/search?f_Guideline_Developer_String=American%20Occupational%20Therapy%20Association%2C%20Inc.&amp;fLockTerm=American%2BOccupational%2BTherapy%2BAssociation%252c%2BInc.">American Occupational Therapy Association, Inc.</a></li>
                        <li>   
                                <a id="165" href="#" data-alert="SignInLanding" data-alert-type="organization" class="get-alerts get-org-alerts">Get Alerts</a>
                        </li>
                </ul>
        </div>
    <!-- /.content-tab-panel -->
    <div id="source-tab" class="content-tab-panel">
<table><tr><td>Preissner K. Occupational therapy practice guidelines for adults with neurodegenerative diseases. Bethesda (MD): American Occupational Therapy Association, Inc. (AOTA); 2014. 187 p.  [225 references]</td></tr></table>                    <p><a href="/web/20180712210301/https://www.guideline.gov/Home/Disclaimer?id=48512&amp;contentType=fulltextlink&amp;redirect=https%253a%252f%252fmyaota.aota.org%252fshop_aota%252fprodview.aspx%253fPID%253d209452232%2526SKU%253d900355%2526TYPE%253dD">View the original guideline documentation</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712210301im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/></p>
    </div>
    <!-- /.content-tab-panel -->
    <div id="status-tab" class="content-tab-panel">
            <p><div class="content_para"><p>This is the current release of the guideline.</p>
<p>This guideline meets NGC's 2013 (revised) inclusion criteria.</p></div></p>
    </div>
    <!-- /.content-tab-panel -->
    <div id="classification-tab" class="content-tab-panel">


        
                    <h4>Age Group</h4>
            <ul>
                        <li><a href="/web/20180712210301/https://www.guideline.gov/search?f_Age_of_Target_Population=Adult%20%2819%20to%2044%20years%29&amp;fLockTerm=Adult%2B%2819%2Bto%2B44%2Byears%29">Adult (19 to 44 years)</a></li>                      
                        <li><a href="/web/20180712210301/https://www.guideline.gov/search?f_Age_of_Target_Population=Aged%20%2865%20to%2079%20years%29&amp;fLockTerm=Aged%2B%2865%2Bto%2B79%2Byears%29">Aged (65 to 79 years)</a></li>                      
                        <li><a href="/web/20180712210301/https://www.guideline.gov/search?f_Age_of_Target_Population=Aged%2C%2080%20and%20over&amp;fLockTerm=Aged%252c%2B80%2Band%2Bover">Aged, 80 and over</a></li>                      
                        <li><a href="/web/20180712210301/https://www.guideline.gov/search?f_Age_of_Target_Population=Middle%20Age%20%2845%20to%2064%20years%29&amp;fLockTerm=Middle%2BAge%2B%2845%2Bto%2B64%2Byears%29">Middle Age (45 to 64 years)</a></li>                      
            </ul>
                    <h4>UMLS Concepts <a href="/web/20180712210301/https://www.guideline.gov/help-and-about/search-browse/umls-concepts" class="what-is">(what is this?)</a></h4>
                <div class="field">
                    <h5 class="field-label">HCPCS</h5>
                    <div class="field-content">
<a href="/web/20180712210301/https://www.guideline.gov/search?f_HCPCS_CUI=C0993877&amp;fLockTerm=Communication+board%2c+non-electronic+augmentative+or+alternative+communication+device">Communication board, non-electronic augmentative or alternative communication device</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">ICD9CM</h5>
                    <div class="field-content">
<a href="/web/20180712210301/https://www.guideline.gov/search?f_ICD9CM_CUI=C0270627&amp;fLockTerm=Acute+(transverse)+myelitis+NOS">Acute (transverse) myelitis NOS</a>
 (341.20), <a href="/web/20180712210301/https://www.guideline.gov/search?f_ICD9CM_CUI=C0002736&amp;fLockTerm=Amyotrophic+lateral+sclerosis">Amyotrophic lateral sclerosis</a>
 (335.20), <a href="/web/20180712210301/https://www.guideline.gov/search?f_ICD9CM_CUI=C0026769&amp;fLockTerm=Multiple+sclerosis">Multiple sclerosis</a>
 (340), <a href="/web/20180712210301/https://www.guideline.gov/search?f_ICD9CM_CUI=C1318464&amp;fLockTerm=Occupational+therapy">Occupational therapy</a>
 (93.83), <a href="/web/20180712210301/https://www.guideline.gov/search?f_ICD9CM_CUI=C0030567&amp;fLockTerm=Paralysis+agitans">Paralysis agitans</a>
 (332.0), <a href="/web/20180712210301/https://www.guideline.gov/search?f_ICD9CM_CUI=C0034996&amp;fLockTerm=Vocational+rehabilitation">Vocational rehabilitation</a>
 (93.85)                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">MSH</h5>
                    <div class="field-content">
<a href="/web/20180712210301/https://www.guideline.gov/search?f_MSH_CUI=C0002423&amp;fLockTerm=Ambulatory+Care">Ambulatory Care</a>
, <a href="/web/20180712210301/https://www.guideline.gov/search?f_MSH_CUI=C0002736&amp;fLockTerm=Amyotrophic+Lateral+Sclerosis">Amyotrophic Lateral Sclerosis</a>
, <a href="/web/20180712210301/https://www.guideline.gov/search?f_MSH_CUI=C0009429&amp;fLockTerm=Combined+Modality+Therapy">Combined Modality Therapy</a>
, <a href="/web/20180712210301/https://www.guideline.gov/search?f_MSH_CUI=C0010439&amp;fLockTerm=Cues">Cues</a>
, <a href="/web/20180712210301/https://www.guideline.gov/search?f_MSH_CUI=C0013787&amp;fLockTerm=Electric+Stimulation+Therapy">Electric Stimulation Therapy</a>
, <a href="/web/20180712210301/https://www.guideline.gov/search?f_MSH_CUI=C0557904&amp;fLockTerm=Emotional+Adjustment">Emotional Adjustment</a>
, <a href="/web/20180712210301/https://www.guideline.gov/search?f_MSH_CUI=C0015259&amp;fLockTerm=Exercise">Exercise</a>
, <a href="/web/20180712210301/https://www.guideline.gov/search?f_MSH_CUI=C0452240&amp;fLockTerm=Exercise+Therapy">Exercise Therapy</a>
, <a href="/web/20180712210301/https://www.guideline.gov/search?f_MSH_CUI=C0018738&amp;fLockTerm=Health+Promotion">Health Promotion</a>
, <a href="/web/20180712210301/https://www.guideline.gov/search?f_MSH_CUI=C0019855&amp;fLockTerm=Home+Care+Services">Home Care Services</a>
, <a href="/web/20180712210301/https://www.guideline.gov/search?f_MSH_CUI=C0019993&amp;fLockTerm=Hospitalization">Hospitalization</a>
, <a href="/web/20180712210301/https://www.guideline.gov/search?f_MSH_CUI=C0020311&amp;fLockTerm=Hydrotherapy">Hydrotherapy</a>
, <a href="/web/20180712210301/https://www.guideline.gov/search?f_MSH_CUI=C0026606&amp;fLockTerm=Motor+Activity">Motor Activity</a>
, <a href="/web/20180712210301/https://www.guideline.gov/search?f_MSH_CUI=C0026769&amp;fLockTerm=Multiple+Sclerosis">Multiple Sclerosis</a>
, <a href="/web/20180712210301/https://www.guideline.gov/search?f_MSH_CUI=C1720868&amp;fLockTerm=Muscle+Stretching+Exercises">Muscle Stretching Exercises</a>
, <a href="/web/20180712210301/https://www.guideline.gov/search?f_MSH_CUI=C0026976&amp;fLockTerm=Myelitis%2c+Transverse">Myelitis, Transverse</a>
, <a href="/web/20180712210301/https://www.guideline.gov/search?f_MSH_CUI=C0524851&amp;fLockTerm=Neurodegenerative+Diseases">Neurodegenerative Diseases</a>
, <a href="/web/20180712210301/https://www.guideline.gov/search?f_MSH_CUI=C1318464&amp;fLockTerm=Occupational+Therapy">Occupational Therapy</a>
, <a href="/web/20180712210301/https://www.guideline.gov/search?f_MSH_CUI=C0030567&amp;fLockTerm=Parkinson+Disease">Parkinson Disease</a>
, <a href="/web/20180712210301/https://www.guideline.gov/search?f_MSH_CUI=C0030679&amp;fLockTerm=Patient+Care+Team">Patient Care Team</a>
, <a href="/web/20180712210301/https://www.guideline.gov/search?f_MSH_CUI=C0034996&amp;fLockTerm=Rehabilitation%2c+Vocational">Rehabilitation, Vocational</a>
, <a href="/web/20180712210301/https://www.guideline.gov/search?f_MSH_CUI=C0872279&amp;fLockTerm=Resistance+Training">Resistance Training</a>
, <a href="/web/20180712210301/https://www.guideline.gov/search?f_MSH_CUI=C0036605&amp;fLockTerm=Self-Help+Devices">Self-Help Devices</a>
, <a href="/web/20180712210301/https://www.guideline.gov/search?f_MSH_CUI=C0376403&amp;fLockTerm=Tai+Ji">Tai Ji</a>
, <a href="/web/20180712210301/https://www.guideline.gov/search?f_MSH_CUI=C0162648&amp;fLockTerm=Telemedicine">Telemedicine</a>
, <a href="/web/20180712210301/https://www.guideline.gov/search?f_MSH_CUI=C0039799&amp;fLockTerm=Therapy%2c+Computer-Assisted">Therapy, Computer-Assisted</a>
, <a href="/web/20180712210301/https://www.guideline.gov/search?f_MSH_CUI=C0043143&amp;fLockTerm=Wheelchairs">Wheelchairs</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">MTH</h5>
                    <div class="field-content">
<a href="/web/20180712210301/https://www.guideline.gov/search?f_MTH_CUI=C0002423&amp;fLockTerm=ambulatory+care+services">ambulatory care services</a>
, <a href="/web/20180712210301/https://www.guideline.gov/search?f_MTH_CUI=C0002736&amp;fLockTerm=Amyotrophic+Lateral+Sclerosis">Amyotrophic Lateral Sclerosis</a>
, <a href="/web/20180712210301/https://www.guideline.gov/search?f_MTH_CUI=C0009429&amp;fLockTerm=Combined+Modality+Therapy">Combined Modality Therapy</a>
, <a href="/web/20180712210301/https://www.guideline.gov/search?f_MTH_CUI=C0013787&amp;fLockTerm=Electric+Stimulation+Therapy">Electric Stimulation Therapy</a>
, <a href="/web/20180712210301/https://www.guideline.gov/search?f_MTH_CUI=C0557904&amp;fLockTerm=Emotional+Adjustment">Emotional Adjustment</a>
, <a href="/web/20180712210301/https://www.guideline.gov/search?f_MTH_CUI=C0015259&amp;fLockTerm=Exercise">Exercise</a>
, <a href="/web/20180712210301/https://www.guideline.gov/search?f_MTH_CUI=C0018738&amp;fLockTerm=Health+Promotion">Health Promotion</a>
, <a href="/web/20180712210301/https://www.guideline.gov/search?f_MTH_CUI=C0019855&amp;fLockTerm=Home+Care+Services">Home Care Services</a>
, <a href="/web/20180712210301/https://www.guideline.gov/search?f_MTH_CUI=C0019993&amp;fLockTerm=Hospitalization">Hospitalization</a>
, <a href="/web/20180712210301/https://www.guideline.gov/search?f_MTH_CUI=C0020311&amp;fLockTerm=Hydrotherapy">Hydrotherapy</a>
, <a href="/web/20180712210301/https://www.guideline.gov/search?f_MTH_CUI=C0184575&amp;fLockTerm=Mobility+deficit+therapy">Mobility deficit therapy</a>
, <a href="/web/20180712210301/https://www.guideline.gov/search?f_MTH_CUI=C0026769&amp;fLockTerm=Multiple+Sclerosis">Multiple Sclerosis</a>
, <a href="/web/20180712210301/https://www.guideline.gov/search?f_MTH_CUI=C0524851&amp;fLockTerm=Neurodegenerative+Disorders">Neurodegenerative Disorders</a>
, <a href="/web/20180712210301/https://www.guideline.gov/search?f_MTH_CUI=C1318464&amp;fLockTerm=Occupational+therapy+regime">Occupational therapy regime</a>
, <a href="/web/20180712210301/https://www.guideline.gov/search?f_MTH_CUI=C0030567&amp;fLockTerm=Parkinson+Disease">Parkinson Disease</a>
, <a href="/web/20180712210301/https://www.guideline.gov/search?f_MTH_CUI=C0026606&amp;fLockTerm=Physical+activity">Physical activity</a>
, <a href="/web/20180712210301/https://www.guideline.gov/search?f_MTH_CUI=C0452240&amp;fLockTerm=Physical+therapy+exercises">Physical therapy exercises</a>
, <a href="/web/20180712210301/https://www.guideline.gov/search?f_MTH_CUI=C0872279&amp;fLockTerm=Resistance+Training">Resistance Training</a>
, <a href="/web/20180712210301/https://www.guideline.gov/search?f_MTH_CUI=C0162648&amp;fLockTerm=Telemedicine">Telemedicine</a>
, <a href="/web/20180712210301/https://www.guideline.gov/search?f_MTH_CUI=C0034996&amp;fLockTerm=Vocational+rehabilitation">Vocational rehabilitation</a>
, <a href="/web/20180712210301/https://www.guideline.gov/search?f_MTH_CUI=C0043143&amp;fLockTerm=wheelchair">wheelchair</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">PDQ</h5>
                    <div class="field-content">
<a href="/web/20180712210301/https://www.guideline.gov/search?f_PDQ_CUI=C0279757&amp;fLockTerm=fatigue+assessment%2fmanagement">fatigue assessment/management</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">SNOMEDCT_US</h5>
                    <div class="field-content">
<a href="/web/20180712210301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0270627&amp;fLockTerm=Acute+transverse+myelitis">Acute transverse myelitis</a>
 (47000000), <a href="/web/20180712210301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0002736&amp;fLockTerm=Amyotrophic+lateral+sclerosis">Amyotrophic lateral sclerosis</a>
 (86044005), <a href="/web/20180712210301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0036605&amp;fLockTerm=Assistive+equipment">Assistive equipment</a>
 (360296002), <a href="/web/20180712210301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0579088&amp;fLockTerm=Cognitive+skills+training">Cognitive skills training</a>
 (302259009), <a href="/web/20180712210301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0557904&amp;fLockTerm=Emotional+adjustment">Emotional adjustment</a>
 (225004003), <a href="/web/20180712210301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0015259&amp;fLockTerm=Exercise">Exercise</a>
 (183301007), <a href="/web/20180712210301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0015259&amp;fLockTerm=Exercise">Exercise</a>
 (256235009), <a href="/web/20180712210301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0015259&amp;fLockTerm=Exercise">Exercise</a>
 (61686008), <a href="/web/20180712210301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0018738&amp;fLockTerm=Health+promotion">Health promotion</a>
 (171434007), <a href="/web/20180712210301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0020311&amp;fLockTerm=Hydrotherapy">Hydrotherapy</a>
 (46903006), <a href="/web/20180712210301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0019993&amp;fLockTerm=Inpatient+care">Inpatient care</a>
 (394656005), <a href="/web/20180712210301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C1443428&amp;fLockTerm=Memory+loss+care+management">Memory loss care management</a>
 (408901004), <a href="/web/20180712210301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C1269740&amp;fLockTerm=Mobility+deficit+management">Mobility deficit management</a>
 (370869008), <a href="/web/20180712210301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0184575&amp;fLockTerm=Mobility+deficit+therapy">Mobility deficit therapy</a>
 (370867005), <a href="/web/20180712210301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0026769&amp;fLockTerm=Multiple+sclerosis">Multiple sclerosis</a>
 (192928003), <a href="/web/20180712210301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0026769&amp;fLockTerm=Multiple+sclerosis">Multiple sclerosis</a>
 (24700007), <a href="/web/20180712210301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C1318464&amp;fLockTerm=Occupational+therapy">Occupational therapy</a>
 (84478008), <a href="/web/20180712210301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0002423&amp;fLockTerm=Outpatient+service">Outpatient service</a>
 (7271000175108), <a href="/web/20180712210301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0030567&amp;fLockTerm=Parkinson%27s+disease">Parkinson&#39;s disease</a>
 (49049000), <a href="/web/20180712210301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0026606&amp;fLockTerm=Physical+activity">Physical activity</a>
 (48761009), <a href="/web/20180712210301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0026606&amp;fLockTerm=Physical+activity">Physical activity</a>
 (68130003), <a href="/web/20180712210301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0150777&amp;fLockTerm=Social+skills+training">Social skills training</a>
 (228559006), <a href="/web/20180712210301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0376403&amp;fLockTerm=Tai-chi">Tai-chi</a>
 (30900002), <a href="/web/20180712210301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0013787&amp;fLockTerm=Therapeutic+electrical+stimulation">Therapeutic electrical stimulation</a>
 (169430000), <a href="/web/20180712210301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0013787&amp;fLockTerm=Therapeutic+electrical+stimulation">Therapeutic electrical stimulation</a>
 (57942008), <a href="/web/20180712210301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0452240&amp;fLockTerm=Therapeutic+exercise">Therapeutic exercise</a>
 (226029000), <a href="/web/20180712210301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0452240&amp;fLockTerm=Therapeutic+exercise">Therapeutic exercise</a>
 (229065009), <a href="/web/20180712210301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0452240&amp;fLockTerm=Therapeutic+exercise">Therapeutic exercise</a>
 (51998003), <a href="/web/20180712210301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0026976&amp;fLockTerm=Transverse+myelopathy+syndrome">Transverse myelopathy syndrome</a>
 (16631009), <a href="/web/20180712210301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0034996&amp;fLockTerm=Vocational+rehabilitation">Vocational rehabilitation</a>
 (70082004), <a href="/web/20180712210301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0043143&amp;fLockTerm=Wheelchair">Wheelchair</a>
 (58938008)                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">UMD</h5>
                    <div class="field-content">
<a href="/web/20180712210301/https://www.guideline.gov/search?f_UMD_CUI=C2720668&amp;fLockTerm=Controllers%2c+Disabled-Patient-Assistance%2c+Voice-Activated">Controllers, Disabled-Patient-Assistance, Voice-Activated</a>
 (24-029), <a href="/web/20180712210301/https://www.guideline.gov/search?f_UMD_CUI=C0043143&amp;fLockTerm=Wheelchairs">Wheelchairs</a>
 (14-449)                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
    </div>
        <!-- /.content-tab-panel -->
        <!-- /.content-tab-panel -->
        <!-- TOOLBAR -->
        <div class="content-toolbar">

            <!-- Primary -->
            <ul class="tools primary-tools">
                <li class="dropdown tool sections">
                    <a href="#" class="tool-button">Sections</a>
                    <div class="dropdown-panel">
                            <ul class="section-links">
                                    <li><a href="#420" class="section-mark">Recommendations</a></li>
                                    <li><a href="#396" class="section-mark">Scope</a></li>
                                    <li><a href="#405" class="section-mark">Methodology</a></li>
                                    <li><a href="#424" class="section-mark">Evidence Supporting the Recommendations</a></li>
                                    <li><a href="#427" class="section-mark">Benefits/Harms of Implementing the Guideline Recommendations</a></li>
                                    <li><a href="#432" class="section-mark">Qualifying Statements</a></li>
                                    <li><a href="#434" class="section-mark">Implementation of the Guideline</a></li>
                                    <li><a href="#439" class="section-mark">Institute of Medicine (IOM) National Healthcare Quality Report Categories</a></li>
                                    <li><a href="#442" class="section-mark">Identifying Information and Availability</a></li>
                                    <li><a href="#99999" class="section-mark">Disclaimer</a></li>
                            </ul>    
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
            </ul>

            <!-- Other -->
            <ul class="tools other-tools">
                <li class="dropdown tool">
                    <a href="#" class="tool-button">Download</a>

                    <div class="dropdown-panel">
                        <ul>
                            <li><a href="/web/20180712210301/https://www.guideline.gov/summaries/downloadcontent/ngc-10522?contentType=pdf" class="pdf">.PDF 111.5 kb</a></li>
                            <li><a href="/web/20180712210301/https://www.guideline.gov/summaries/downloadcontent/ngc-10522?contentType=word" class="word">Word Document 307.4 kb</a></li>
                            <li><a href="/web/20180712210301/https://www.guideline.gov/summaries/downloadcontent/ngc-10522?contentType=xml" class="xml">.XML 55.6 kb</a></li>
                        </ul>
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
                <li class="dropdown tool">
                    <a href="#" class="tool-button">Share</a>
                    <div class="dropdown-panel">
                        <ul class="toolbar-social">
                            <li><a target="_blank" href="https://web.archive.org/web/20180712210301/https://www.facebook.com/sharer/sharer.php?u=https://www.guideline.gov/summaries/summary/48512/occupational-therapy-practice-guidelines-for-adults-with-neurodegenerative-diseases" class="facebook">Facebook</a></li>
                            <li><a target="_blank" href="https://web.archive.org/web/20180712210301/https://twitter.com/share?text=&amp;url=https://www.guideline.gov/summaries/summary/48512/occupational-therapy-practice-guidelines-for-adults-with-neurodegenerative-diseases" class="twitter">Twitter</a></li>
                            <li><a target="_blank" href="https://web.archive.org/web/20180712210301/https://www.linkedin.com/shareArticle?mini=true&amp;url=https://www.guideline.gov/summaries/summary/48512/occupational-therapy-practice-guidelines-for-adults-with-neurodegenerative-diseases&amp;title=&amp;summary=&amp;source=" class="linkedin">Linkedin</a></li>
                            <li><a href="https://web.archive.org/web/20180712210301/mailto:/?Subject=AHRQ: Occupational therapy practice guidelines for adults with neurodegenerative diseases.&amp;body=https://www.guideline.gov/summaries/summary/48512/occupational-therapy-practice-guidelines-for-adults-with-neurodegenerative-diseases" class="email">Email</a></li>
                        </ul>
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
                <li class="dropdown tool">
                    <a href="#" class="tool-button">Cite</a>
                    <div class="dropdown-panel citation">
                        <p class="text-label"><label for="citation">Citation: </label></p>
                        <textarea id="citation">National Guideline Clearinghouse (NGC). Guideline summary: Occupational therapy practice guidelines for adults with neurodegenerative diseases. In: National Guideline Clearinghouse (NGC) [Web site]. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ); 2014 Jan 01. [cited 2018 Jul 12]. Available: https://www.guideline.gov</textarea>                        
                        <p class="text-label">Download citation file: </p>
                        <ul>
                            <li><a href="/web/20180712210301/https://www.guideline.gov/summaries/citedownload/48512?format=ris">RIS (Zotero)</a></li>
                            <li><a href="/web/20180712210301/https://www.guideline.gov/summaries/citedownload/48512?format=enw">EndNote</a></li>
                            <li><a href="/web/20180712210301/https://www.guideline.gov/summaries/citedownload/48512?format=bibtex">BibTex</a></li>
                            <li><a href="/web/20180712210301/https://www.guideline.gov/summaries/citedownload/48512?format=txt">Medlars</a></li>
                            <li><a href="/web/20180712210301/https://www.guideline.gov/summaries/citedownload/48512?format=ris">ProCite</a></li>
                            <li><a href="/web/20180712210301/https://www.guideline.gov/summaries/citedownload/48512">RefWorks</a></li>
                            <li><a href="/web/20180712210301/https://www.guideline.gov/summaries/citedownload/48512?format=ris">Reference Manager</a></li>
                        </ul>
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
                                
                <li class="tool">
                        <a href="#" id="48512" data-alert="SignInLanding" class="tool-button save-link">Save</a>
                </li>
            </ul>

            <!-- Accordion -->
            <ul class="tools accordion-controls">
                <li class="tool"><a href="#" class="expand-all is-disabled" aria-disabled="true"><span class="screen-reader-text">Expand All</span></a></li>
                <li class="tool"><a href="#" class="collapse-all" aria-disabled="false"><span class="screen-reader-text">Collapse All</span></a></li>
            </ul>
        </div>
        <!-- /.toolbar -->


		<!-- ARTICLE -->
		<div class="article" id="article">
			




    <!-- ACCORDION -->
    <div class="accordion-container" role="tablist" multiselectable="true">
                <h2 id="420" class="accordion-title section-420 is-active" role="tab" aria-expanded="true"><a href="#">Recommendations</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Major Recommendations</a></h3>
                    <p><div class="content_para"><p><strong><em>Note from the National Guideline Clearinghouse</em></strong>: In addition to the evidence-based recommendations below, the guideline includes extensive information on the evaluation process and intervention strategies for people with multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), Parkinson's disease (PD), and transverse myelitis (TM).</p>
<p>Definitions for the strength of recommendations (<strong>A&ndash;D, I</strong>) and levels of evidence (<strong>I&ndash;V</strong>) are provided at the end of the "Major Recommendations" field.</p>
<p><strong><span style="text-decoration: underline;">Recommendations for Occupational Therapy Interventions for Adults with Neurodegenerative Diseases</span></strong></p>
<p><strong>Multiple Sclerosis</strong></p>
<p><em>Interventions Focusing on Activity and Participation</em></p>
<ul style="list-style-type: disc;">
    <li>Face-to-face fatigue management programs to reduce the impact of fatigue, improve quality of life (QoL), and improve self-efficacy for using fatigue management strategies (<strong>A</strong>) </li>
    <li>Teleconference-delivered fatigue management programs to reduce the impact of fatigue on daily life and to improve QoL (<strong>A</strong>) </li>
    <li>Multidisciplinary rehabilitation provided in a variety of settings to improve levels of activity and participation and health-related QoL (<strong>A</strong>) </li>
    <li>Outpatient rehabilitation programs for people with MS to improve health and QoL, reduce the impact of fatigue, and improve social functioning (<strong>B</strong>) </li>
    <li>Inpatient rehabilitation to reduce disease severity and improve&nbsp;activities of daily living (ADL) status (<strong>B</strong>) </li>
    <li>A home-based program to improve performance (<strong>B</strong>) </li>
    <li>Outpatient rehabilitation to improve ADL performance (<strong>B</strong>) </li>
    <li>Health promotion programs to improve health, increase physical activity and spiritual growth, and reduce stress (<strong>C</strong>) </li>
    <li>Vocational rehabilitation (<strong>I</strong>) </li>
    <li>Program to improve functional mobility (<strong>I</strong>) </li>
</ul>
<p><em>Interventions Focusing on Performance Skills</em></p>
<p><span style="text-decoration: underline;">Social Interaction Skills</span></p>
<ul style="list-style-type: disc;">
    <li>Emotion regulation interventions to improve mood, reduce levels of depression, reduce stress, and improve self-efficacy (<strong>A</strong>) </li>
</ul>
<p><span style="text-decoration: underline;">Process Skills</span></p>
<ul style="list-style-type: disc;">
    <li>Home-based, individualized, and computerized cognitive training to improve attention, memory, information processing, and executive functions (<strong>B</strong>) </li>
    <li>Memory training to improve memory on a short-term basis (<strong>B</strong>) </li>
</ul>
<p><span style="text-decoration: underline;">Motor Skills</span></p>
<ul style="list-style-type: disc;">
    <li>Physical activity programs to improve muscle power and mobility (<strong>A</strong>) </li>
    <li>Aerobic activity programs to improve walking distance, endurance, and QoL (<strong>A</strong>) </li>
    <li>Resistance training to improve speed and endurance (<strong>B</strong>) </li>
    <li>Motor training to restore neuromusculoskeletal and movement-related functions and motor and praxis skills (<strong>I</strong>) </li>
</ul>
<p><strong>Parkinson's Disease</strong></p>
<p><em>Engagement in Exercise and Physical Activity to Improve Performance Skills and Occupational Performance</em></p>
<ul style="list-style-type: disc;">
    <li>Multisession, repetitive physical exercise (diachronic) to improve motor and sensory&ndash;perceptual performance skills (<strong>A or B</strong>) </li>
    <li>Specialized forms of exercise or more intense task-specific exercise (diachronic) to improve performance more than usual forms or less intense exercise (<strong>C</strong>) </li>
    <li>Single-task interventions in a single session to improve skill development (<strong>C</strong>) </li>
</ul>
<p><em>Occupational Performance</em></p>
<ul style="list-style-type: disc;">
    <li>Environmental cues, stimuli, and assistive objects to improve task and occupational performance. (<strong>B</strong>) </li>
    <li>Auditory rhythmic external cues, which are more effective than visual, tactile, or other forms of cues, to help regulate walking in PD (<strong>B</strong>) </li>
    <li>Client-preferred external cues during ADLs to improve motor control (<strong>B</strong>) </li>
    <li>Individualized interventions focusing on participant wellness, lifestyle modification, and personal control to improve QoL (<strong>B</strong>) </li>
    <li>Complex and multimodal activity (e.g., tango dancing) to improve functional movement on a short-term basis (<strong>B</strong>) </li>
    <li>Tai chi to enhance motor and postural performance skills in PD (<strong>C</strong>) </li>
    <li>Multimodal physical activity to improve cognitive performance, particularly executive functioning (<strong>C</strong>) </li>
    <li>Avoidance of environmental cues that divide attention or focus attention away from the primary task or elicit negative emotions (<strong>D</strong>) </li>
</ul>
<p><strong>Amyotrophic Lateral Sclerosis</strong></p>
<ul style="list-style-type: disc;">
    <li>Home exercise program of daily stretching and resistance exercise improves functional outcome with no adverse effects. (<strong>B</strong>) </li>
    <li>Participating in a multidisciplinary program improves survival as compared with general care. (<strong>C to B</strong>) </li>
    <li>A supervised exercise program to maintain functional capacity is better than a home exercise program. (<strong>C</strong>) </li>
    <li>Participating in a multidisciplinary program results in a higher percentage of use of appropriate assistive devices and a higher QoL in social functioning and mental health than general care. (<strong>C</strong>) </li>
    <li>Power wheelchair (PWC) users are satisfied with ease of use and comfort, and PWCs can include tilt, recline, head, neck, trunk, and extremity supports; power elevating leg rests; ability to run power features through joystick with upgraded electronics; air or gel cushion; soft headrest; seatbelts; and height-adjustable flat, gel, or contoured armrests. (<strong>C</strong>) </li>
    <li>PWCs facilitate participation in activities as compared with manual wheelchairs. (<strong>C</strong>) </li>
    <li>Manual wheelchairs provide ease of portability as compared with PWCs. (<strong>C</strong>) </li>
    <li>High degrees of usefulness and satisfaction are reported for elevated toilet seat, rails by toilet, shower seat, shower bars, slip-on shoes, ankle brace, and transfer board. (<strong>C</strong>) </li>
    <li>High degrees of satisfaction but infrequent use are reported for sound- or voice-activated environmental controls and communication boards. (<strong>C</strong>) </li>
    <li>Low degrees of usefulness and satisfaction are reported for buttonhooks, dressing sticks, and long-handled reaching tools. (<strong>C</strong>) </li>
    <li>Telemedicine is reported as useful and satisfying to persons with ALS, except for discussions of psychological and emotional concerns. (<strong>C</strong>) </li>
    <li>Using a computer program for writing messages and choosing songs and videos through a virtual keyboard and microswitch are reported as useful. (<strong>I</strong>) </li>
    <li>Electrical stimulation can improve bilateral hand function and knee extension. (<strong>I</strong>) </li>
    <li>Aquatic therapy is helpful to increase energy and reduce assistance for transfers after therapy. (<strong>I</strong>) </li>
    <li>Sling back and sling seats are reported to be not helpful or satisfying to wheelchair users. (<strong>D</strong>) </li>
</ul>
<p class="Note"><strong>Note</strong>: Criteria for level of evidence and recommendations (A, B, C, I, D) are based on standard language from the Agency for Healthcare Research and Quality (2012). Suggested recommendations are based on the available evidence and content experts' clinical expertise regarding the value of using it.</p>
<p><strong><span style="text-decoration: underline;">Definitions</span></strong>:</p>
<p><strong>Levels of Evidence for Occupational Therapy Outcomes Research</strong></p>
<table border="1" cellspacing="1" cellpadding="3" summary="Table: Levels of Evidence for Occupational Therapy Outcomes Research">
    <thead>
        <tr>
            <th valign="top" scope="col">Evidence Level</th>
            <th valign="top" scope="col">Definitions</th>
        </tr>
    </thead>
    <tbody>
        <tr>
            <th valign="top">I</th>
            <td valign="top">Systematic reviews, meta-analyses, randomized controlled trials</td>
        </tr>
        <tr>
            <th valign="top">II</th>
            <td valign="top">Two groups, nonrandomized studies (e.g., cohort, case control)</td>
        </tr>
        <tr>
            <th valign="top">III</th>
            <td valign="top">One group, nonrandomized (e.g., before and after, pretest and posttest) </td>
        </tr>
        <tr>
            <th valign="top">IV</th>
            <td valign="top">Descriptive studies that include analysis of outcomes (e.g., single-subject design, case series)</td>
        </tr>
        <tr>
            <th valign="top">V</th>
            <td valign="top">Case reports and expert opinion that include narrative literature reviews and consensus statements</td>
        </tr>
    </tbody>
</table>
<p class="Note"><strong>Note</strong>: Adapted from "Evidence-based medicine: What it is and what it isn't." D. L. Sackett, W. M. Rosenberg, J. A. Muir Gray, R. B. Haynes, &amp; W. S. Richardson, 1996, <em>British Medical Journal</em>, 312, pp. 71-72. Copyright &copy; 1996 by the British Medical Association. Adapted with permission.</p>
<p><strong>Strength of Recommendations</strong></p>
<p><strong>A</strong>&ndash;There is strong evidence that occupational therapy practitioners should routinely provide the intervention to eligible clients. Good evidence was found that the intervention improves important outcomes and concludes that benefits substantially outweigh harm.</p>
<p><strong>B</strong>&ndash;There is moderate evidence that occupational therapy practitioners should routinely provide the intervention to eligible clients. There is high certainty that the net benefit is moderate, or there is moderate certainty that the net benefit is moderate to substantial.</p>
<p><strong>C</strong>&ndash;There is weak evidence that the intervention can improve outcomes. It is recommended that the intervention be provided selectively on the basis of professional judgment and patient preferences. There is at least moderate certainty that the net benefit is small.</p>
<p><strong>I</strong>&ndash;There is insufficient evidence to determine whether or not occupational therapy practitioners should be routinely providing the intervention. Evidence that the intervention is effective is lacking, of poor quality, or conflicting and the balance of benefits and harm cannot be determined.</p>
<p><strong>D</strong>&ndash;It is recommended that occupational therapy practitioners not provide the intervention to eligible clients. At least fair evidence was found that the intervention is ineffective or that harm outweighs benefits.</p></div></p>
                        <h3><a href="#">Clinical Algorithm(s)</a></h3>
                    <p><div class="content_para"><p>None provided</p></div></p>

            </div>
                <h2 id="396" class="accordion-title section-396 is-active" role="tab" aria-expanded="true"><a href="#">Scope</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Disease/Condition(s)</a></h3>
                    <p><div class="content_para"><p>Neurodegenerative diseases (NDDs), specifically:</p>
<ul style="list-style-type: disc;">
    <li>Multiple sclerosis (MS) </li>
    <li>Parkinson's disease (PD) </li>
    <li>Amyotrophic lateral sclerosis (ALS) </li>
    <li>Transverse myelitis (TM) </li>
</ul></div></p>
                        <h3><a href="#">Guideline Category</a></h3>
                    <p>Counseling</p>
                    <p>Management</p>
                    <p>Rehabilitation</p>
                        <h3><a href="#">Clinical Specialty</a></h3>
                    <p>Family Practice</p>
                    <p>Internal Medicine</p>
                    <p>Neurology</p>
                    <p>Physical Medicine and Rehabilitation</p>
                        <h3><a href="#">Intended Users</a></h3>
                    <p>Advanced Practice Nurses</p>
                    <p>Allied Health Personnel</p>
                    <p>Health Care Providers</p>
                    <p>Health Plans</p>
                    <p>Managed Care Organizations</p>
                    <p>Nurses</p>
                    <p>Occupational Therapists</p>
                    <p>Patients</p>
                    <p>Physical Therapists</p>
                    <p>Physician Assistants</p>
                    <p>Physicians</p>
                    <p>Public Health Departments</p>
                    <p>Social Workers</p>
                    <p>Students</p>
                    <p>Utilization Management</p>
                        <h3><a href="#">Guideline Objective(s)</a></h3>
                    <p><ul style="list-style-type: disc;">
    <li>To provide an overview of the occupational therapy process for adults with neurodegenerative diseases (NDD), specifically multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), Parkinson's disease (PD), and transverse myelitis (TM) </li>
    <li>To define the occupational therapy domain and process and interventions that occur within the boundaries of acceptable practice </li>
    <li>To help occupational therapists and occupational therapy assistants, as well as the individuals who manage, reimburse, or set policy regarding occupational therapy services, understand the contribution of occupational therapy in providing services to adults with NDD </li>
    <li>To serve as a reference for health care professionals, health care facility managers, education and health care regulators, third-party payers, and managed care organizations </li>
</ul></p>
                        <h3><a href="#">Target Population</a></h3>
                    <p><div class="content_para"><p>Adult with neurodegenerative diseases (NDDs), specifically multiple sclerosis (MS), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and transverse myelitis (TM)</p></div></p>
                        <h3><a href="#">Interventions and Practices Considered</a></h3>
                    <p><div class="content_para"><p><strong>Multiple Sclerosis (MS)</strong></p>
<ol style="list-style-type: decimal;" start="1">
    <li>Focus on activity and participation
    <ul style="list-style-type: disc;">
        <li>Fatigue management (face-to-face and teleconference-delivered management programs) </li>
        <li>Multidisciplinary, outpatient, inpatient and vocational rehabilitation </li>
        <li>Home-based programs </li>
        <li>Health promotion programs </li>
        <li>Improvement of functional mobility </li>
    </ul>
    </li>
    <li>Focus on performance skills
    <ul style="list-style-type: disc;">
        <li>Social interaction skills (emotion regulation interventions) </li>
        <li>Process skills (cognition and memory regulation) </li>
        <li>Exercise and motor training </li>
    </ul>
    </li>
</ol>
<p><strong>Parkinson's Disease (PD)</strong></p>
<ol style="list-style-type: decimal;" start="1">
    <li>Exercise and physical activity </li>
    <li>Occupational performance
    <ul style="list-style-type: disc;">
        <li>Use of environmental cues, stimuli and objects </li>
        <li>Auditory rhythmic external cues </li>
        <li>Individualized interventions focusing on participant wellness </li>
        <li>Complex and multimodal activity (tai chi) </li>
    </ul>
    </li>
</ol>
<p><strong>Amyotrophic Lateral Sclerosis (ALS)</strong></p>
<ol style="list-style-type: decimal;" start="1">
    <li>Exercise (daily stretching, resistance exercise, aquatic therapy) </li>
    <li>Multidisciplinary programs </li>
    <li>Assistive devices and wheelchairs </li>
    <li>Sound- or voice-activated environmental controls and communication boards </li>
    <li>Computer programs (virtual keyboard and microswitch) </li>
    <li>Electrical stimulation </li>
</ol></div></p>
                        <h3><a href="#">Major Outcomes Considered</a></h3>
                    <p><ul style="list-style-type: disc;">
    <li>Greater self-efficacy </li>
    <li>Reduction of disease symptoms </li>
    <li>Reduced levels of depression </li>
    <li>Quality of life (QoL) </li>
</ul></p>

            </div>
                <h2 id="405" class="accordion-title section-405 is-active" role="tab" aria-expanded="true"><a href="#">Methodology</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Methods Used to Collect/Select the Evidence</a></h3>
                    <p>Hand-searches of Published Literature (Primary Sources)</p>
                    <p>Hand-searches of Published Literature (Secondary Sources)</p>
                    <p>Searches of Electronic Databases</p>
                        <h3><a href="#">Description of Methods Used to Collect/Select the Evidence</a></h3>
                    <p><div class="content_para"><p>The following four focused questions from the review of occupational therapy interventions for adults with neurodegenerative diseases framed the reviews:</p>
<ol style="list-style-type: decimal;" start="1">
    <li>What is the effectiveness of interventions within the scope of occupational therapy practice for persons with multiple sclerosis (MS)? </li>
    <li>What is the effectiveness of interventions within the scope of occupational therapy practice for persons with Parkinson's disease (PD)? </li>
    <li>What is the effectiveness of interventions within the scope of occupational therapy practice for persons with amyotrophic lateral sclerosis (ALS)? </li>
    <li>What is the effectiveness of interventions within the scope of occupational therapy practice for persons with transverse myelitis (TM)? </li>
</ol>
<p>Search terms for the reviews were developed by the methodology consultant to the American Occupational Therapy Association, Inc. (AOTA) Evidence-Based Practice Project (EBP) and AOTA staff, in consultation with the authors of each systematic review question, and reviewed by the advisory group. The search terms were developed not only to capture pertinent articles but also to make sure that the terms relevant to the specific thesaurus of each database were included. Table D.2 in the original guideline document lists the search terms related to population and intervention included in each systematic review. A medical research librarian with experience in completing systematic review searches conducted all searches and confirmed and improved the search strategies.</p>
<p>Databases and sites searched included MEDLNE, PsycINFO, CINAHL, AgeLine, and OTseeker. In addition, consolidated information sources, such as the Cochrane Database of Systematic Reviews and the Campbell Collaboration, were included in the search. These databases are peer-reviewed summaries of journal articles and provide a system for clinicians and scientists to conduct evidence-based reviews of selected clinical questions and topics. Moreover, reference lists from articles included in the systematic reviews were examined for potential articles, and selected journals were hand searched to ensure that all appropriate articles were included.</p>
<p>Inclusion and exclusion criteria are critical to the systematic review process because they provide the structure for the quality, type, and years of publication of the literature that is incorporated into a review. The review of all four focused guideline questions was limited to peer-reviewed scientific literature published in English. The intervention approaches examined were within the scope of practice of occupational therapy. The literature included in the review was published between 2003 and 2011 and included study participants with neurodegenerative disease (multiple sclerosis [MS], Parkinson's disease [PD], amyotrophic lateral sclerosis [ALS], transverse myelitis [TM]). The earlier reviews included studies published between 1985 and 2002. The review excluded data from presentations, conference proceedings, non&ndash;peer-reviewed research literature, dissertations, and theses. Studies included in the review are Level I, II, and III evidence. Level IV and V evidence was included only when higher level evidence on a given topic was not found.</p>
<p>A total of 11,672 citations and abstracts were included in the reviews. For the question on MS, there were 3,484 references; for the PD question, 4,061 references; for the ALS question, 872 references; and for the TM question, 149 references.</p>
<p>The consultant to the EBP project completed the first step of eliminating references on the basis of citation and abstract. All articles were eliminated from the initial TM review because none were within the scope of occupational therapy practice, and the results of the review are not discussed in the <em>Practice Guidelines</em>. The systematic reviews for PD and MS were carried out as academic partnerships, in which academic faculty worked with graduate students to carry out the reviews. The systematic review on ALS was carried out as a partnership between the AOTA methodology consultant and an occupational therapist with expertise in ALS. Review teams completed the next step of eliminating references on the basis of citations and abstracts. The full-text versions of potential articles were retrieved, and the review teams determined final inclusion in the review on the basis of predetermined inclusion and exclusion criteria.</p></div></p>
                        <h3><a href="#">Number of Source Documents</a></h3>
                    <p><div class="content_para"><p>A total of 140 articles were included in the final review. The review included 79 Level I studies, 23 Level II studies, 33 Level III studies, 3 Level IV studies, 1 Level V study.</p></div></p>
                        <h3><a href="#">Methods Used to Assess the Quality and Strength of the Evidence</a></h3>
                    <p>Weighting According to a Rating Scheme (Scheme Given)</p>
                        <h3><a href="#">Rating Scheme for the Strength of the Evidence</a></h3>
                    <p><div class="content_para"><p><strong>Levels of Evidence for Occupational Therapy Outcomes Research</strong></p>
<table border="1" cellspacing="1" cellpadding="3" summary="Table: Levels of Evidence for Occupational Therapy Outcomes Research">
    <thead>
        <tr>
            <th valign="top" scope="col">Evidence Level</th>
            <th valign="top" scope="col">Definitions</th>
        </tr>
    </thead>
    <tbody>
        <tr>
            <th valign="top">I</th>
            <td valign="top">Systematic reviews, meta-analyses, randomized controlled trials</td>
        </tr>
        <tr>
            <th valign="top">II</th>
            <td valign="top">Two groups, nonrandomized studies (e.g., cohort, case control)</td>
        </tr>
        <tr>
            <th valign="top">III</th>
            <td valign="top">One group, nonrandomized (e.g., before and after, pretest and posttest) </td>
        </tr>
        <tr>
            <th valign="top">IV</th>
            <td valign="top">Descriptive studies that include analysis of outcomes (e.g., single-subject design, case series)</td>
        </tr>
        <tr>
            <th valign="top">V</th>
            <td valign="top">Case reports and expert opinion that include narrative literature reviews and consensus statements</td>
        </tr>
    </tbody>
</table>
<p class="Note"><strong>Note</strong>: Adapted from "Evidence-based medicine: What it is and what it isn't." D. L. Sackett, W. M. Rosenberg, J. A. Muir Gray, R. B. Haynes, &amp; W. S. Richardson, 1996, <em>British Medical Journal</em>, 312, pp. 71-72. Copyright &copy; 1996 by the British Medical Association. Adapted with permission.</p></div></p>
                        <h3><a href="#">Methods Used to Analyze the Evidence</a></h3>
                    <p>Review of Published Meta-Analyses</p>
                    <p>Systematic Review with Evidence Tables</p>
                        <h3><a href="#">Description of the Methods Used to Analyze the Evidence</a></h3>
                    <p><div class="content_para"><p>The teams working on each focused question reviewed the articles according to their quality (scientific rigor and lack of bias) and levels of evidence. Each article included in the review was then abstracted using an evidence table that provides a summary of the methods and findings of the article and an appraisal of the strengths and weaknesses of the study on the basis of design and methodology. American Occupational Therapy Association Inc. (AOTA) staff and the Evidence-Based Practice (EBP) project consultant reviewed the evidence tables to ensure quality control.</p>
<p>All studies are summarized in full in the evidence tables in Appendix E of the original guideline document. The limitations of the systematic reviews are based on the design and methods of the individual studies, including small sample sizes, high dropout rates, and limited descriptions of the psychometric properties of outcome measures. In addition, many of the studies in the review included concurrent interventions, and separating the effects of a single intervention may be difficult.</p></div></p>
                        <h3><a href="#">Methods Used to Formulate the Recommendations</a></h3>
                    <p>Expert Consensus</p>
                        <h3><a href="#">Description of Methods Used to Formulate the Recommendations</a></h3>
                    <p><div class="content_para"><p>A major focus of the American Occupational Therapy Association (AOTA)'s&nbsp;Evidence-Based Practice (EBP) projects is an ongoing program of systematic review of multidisciplinary scientific literature, using focused questions and standardized procedures to identify practice-relevant evidence and discuss its implications for practice, education, and research. An evidence-based perspective is founded on the assumption that scientific evidence of the effectiveness of occupational therapy intervention can be judged to be more or less strong and valid according to a hierarchy of research designs, an assessment of the quality of the research, or both. AOTA uses standards of evidence modeled on those developed in evidence-based medicine. This model standardizes and ranks the value of scientific evidence for biomedical practice using the grading system presented in the "Rating Scheme for the Strength of the Evidence" field of this summary. In this system, the highest level of evidence, Level I, includes systematic reviews of the literature, meta-analyses and randomized controlled trials (RCTs). In RCTs, participants are randomly allocated to either an intervention or a control group, and the outcomes of both groups are compared. Other levels of evidence include Level II studies, in which assignment to a treatment or a control group is not randomized (cohort study); Level III studies, which do not have a control group; Level IV studies, which use a single-case experimental design, sometimes reported over several participants; and Level V studies, which are case reports and expert opinion that include narrative literature reviews and consensus statements.</p>
<p>The systematic reviews on neurodegenerative diseases were supported by AOTA as part of the EBP Project. AOTA is committed to supporting the role of occupational therapy in this important area of practice. Previous reviews were completed covering the time frame of 1985 to 2002. The current systematic reviews were updated for the period 2003 to 2011 because occupational therapy practitioners need access to the results of the latest and best available literature to support intervention within the scope of occupational therapy practice.</p>
<p>The four focused questions developed for the updated review were based on the search strategy of the earlier review. These questions were reviewed by review authors, an advisory group of experts in the field, AOTA staff, and the consultant to the AOTA EBP Project.</p></div></p>
                        <h3><a href="#">Rating Scheme for the Strength of the Recommendations</a></h3>
                    <p><div class="content_para"><p><strong>Strength of Recommendations</strong></p>
<p><strong>A</strong>&ndash;There is strong evidence that occupational therapy practitioners should routinely provide the intervention to eligible clients. Good evidence was found that the intervention improves important outcomes and concludes that benefits substantially outweigh harm.</p>
<p><strong>B</strong>&ndash;There is moderate evidence that occupational therapy practitioners should routinely provide the intervention to eligible clients. There is high certainty that the net benefit is moderate, or there is moderate certainty that the net benefit is moderate to substantial.</p>
<p><strong>C</strong>&ndash;There is weak evidence that the intervention can improve outcomes. It is recommended that the intervention be provided selectively on the basis of professional judgment and patient preferences. There is at least moderate certainty that the net benefit is small.</p>
<p><strong>I</strong>&ndash;There is insufficient evidence to determine whether or not occupational therapy practitioners should be routinely providing the intervention. Evidence that the intervention is effective is lacking, of poor quality, or conflicting and the balance of benefits and harm cannot be determined.</p>
<p><strong>D</strong>&ndash;It is recommended that occupational therapy practitioners not provide the intervention to eligible clients. At least fair evidence was found that the intervention is ineffective or that harm outweighs benefits.</p></div></p>
                        <h3><a href="#">Cost Analysis</a></h3>
                    <p><div class="content_para"><p>A formal cost analysis was not performed and published analyses were not reviewed.</p></div></p>
                        <h3><a href="#">Method of Guideline Validation</a></h3>
                    <p>Peer Review</p>
                        <h3><a href="#">Description of Method of Guideline Validation</a></h3>
                    <p><div class="content_para"><p>Not stated</p></div></p>

            </div>
                <h2 id="424" class="accordion-title section-424 is-active" role="tab" aria-expanded="true"><a href="#">Evidence Supporting the Recommendations</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Type of Evidence Supporting the Recommendations</a></h3>
                    <p><div class="content_para"><p>The type of supporting evidence is identified and graded for each recommendation (see the "Major Recommendations" field).</p>
<p>The final review included 140 articles. Studies included in the review are Level I, II, and III evidence. Level IV and V evidence was included only when higher level evidence on a given topic was not found.</p>
<table border="1" cellspacing="1" cellpadding="3" summary="Table: Number of Articles in Each Review at Each Level of Evidence">
    <thead>
        <tr>
            <th class="Center" valign="top" colspan="7" scope="col">Number of Articles in Each Review at Each Level of Evidence</th>
        </tr>
        <tr>
            <th class="Center" valign="top" scope="col">&nbsp;</th>
            <th class="Center" valign="top" colspan="5" scope="col">Evidence Level</th>
            <th class="Center" valign="top" scope="col">&nbsp;</th>
        </tr>
        <tr>
            <th valign="top" scope="col">Review</th>
            <th class="Center" valign="top" scope="col">I</th>
            <th class="Center" valign="top" scope="col">II</th>
            <th class="Center" valign="top" scope="col">III</th>
            <th class="Center" valign="top" scope="col">IV</th>
            <th class="Center" valign="top" scope="col">V</th>
            <th class="Center" valign="top" scope="col">Total in Each Review</th>
        </tr>
    </thead>
    <tbody>
        <tr>
            <td valign="top">Parkinson's disease</td>
            <td class="Center" valign="top">35</td>
            <td class="Center" valign="top">7</td>
            <td class="Center" valign="top">13</td>
            <td class="Center" valign="top">0</td>
            <td class="Center" valign="top">0</td>
            <td class="Center" valign="top">55</td>
        </tr>
        <tr>
            <td valign="top">Multiple sclerosis</td>
            <td class="Center" valign="top">41</td>
            <td class="Center" valign="top">13</td>
            <td class="Center" valign="top">16</td>
            <td class="Center" valign="top">0</td>
            <td class="Center" valign="top">0</td>
            <td class="Center" valign="top">70</td>
        </tr>
        <tr>
            <td valign="top">Amyotrophic lateral sclerosis</td>
            <td class="Center" valign="top">3</td>
            <td class="Center" valign="top">3</td>
            <td class="Center" valign="top">4</td>
            <td class="Center" valign="top">3</td>
            <td class="Center" valign="top">1</td>
            <td class="Center" valign="top">14</td>
        </tr>
        <tr>
            <td valign="top">Total</td>
            <td class="Center" valign="top">79</td>
            <td class="Center" valign="top">23</td>
            <td class="Center" valign="top">33</td>
            <td class="Center" valign="top">3</td>
            <td class="Center" valign="top">1</td>
            <td class="Center" valign="top">139</td>
        </tr>
    </tbody>
</table></div></p>

            </div>
                <h2 id="427" class="accordion-title section-427 is-active" role="tab" aria-expanded="true"><a href="#">Benefits/Harms of Implementing the Guideline Recommendations</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Potential Benefits</a></h3>
                    <p><div class="content_para"><p>These guidelines may be used to assist:</p>
<ul style="list-style-type: disc;">
    <li>Occupational therapists and occupational therapy assistants in providing evidence-based interventions to adults with neurodegenerative disease (NDD) </li>
    <li>Occupational therapists and occupational therapy assistants in communicating about their services to external audiences </li>
    <li>Other health care practitioners, case managers, clients, families and caregivers, and health care facility managers in determining whether referral for occupational therapy services is appropriate </li>
    <li>Third-party payers in determining the medical necessity for occupational therapy </li>
    <li>Legislators; third-party payers; federal, state, and local agencies; and administrators in understanding the professional education, training, and skills of occupational therapists and occupational therapy assistants </li>
    <li>Health and social services planning teams in determining the need for occupational therapy </li>
    <li>Program developers; administrators; legislators; federal, state, and local agencies; and third-party payers in understanding the scope of occupational therapy services </li>
    <li>Researchers, occupational therapists, occupational therapy assistants, program evaluators, and policy analysts in this practice area in determining outcome measures for analyzing the effectiveness of occupational therapy intervention </li>
    <li>Policy, education, and health care benefit analysts in understanding the appropriateness of occupational therapy services for adults with NDD </li>
    <li>Policymakers, legislators, and organizations in understanding the contribution occupational therapy can make in health promotion, program development, and health care reform to support adults with NDD </li>
    <li>Occupational therapy educators in designing appropriate curricula that incorporate the role of occupational therapy with adults with NDD </li>
</ul></div></p>
                        <h3><a href="#">Potential Harms</a></h3>
                    <p><div class="content_para"><p>Not stated</p></div></p>

            </div>
                <h2 id="432" class="accordion-title section-432 is-active" role="tab" aria-expanded="true"><a href="#">Qualifying Statements</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Qualifying Statements</a></h3>
                    <p><ul style="list-style-type: disc;">
    <li>This guideline does not discuss all possible methods of care and, although it does recommend some specific methods of care, the occupational therapist makes the ultimate judgment regarding the appropriateness of a given intervention in light of a specific person's or group's circumstances, needs, and the evidence available to support the intervention. </li>
    <li>This publication is designed to provide accurate and authoritative information in regard to the subject matter covered. It is sold or distributed with the understanding that the publisher is not engaged in rendering legal, accounting, or other professional service. If legal advice or other expert assistance is required, the services of a competent professional person should be sought. </li>
    <li>It is the objective of the American Occupational Therapy Association (AOTA) to be a forum for free expression and interchange of ideas. The opinions expressed by the contributors to this work are their own and not necessarily those of AOTA. </li>
</ul></p>

            </div>
                <h2 id="434" class="accordion-title section-434 is-active" role="tab" aria-expanded="true"><a href="#">Implementation of the Guideline</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Description of Implementation Strategy</a></h3>
                    <p><div class="content_para"><p>An implementation strategy was not provided.</p></div></p>
                        <h3><a href="#">Implementation Tools</a></h3>
                    <p>Staff Training/Competency Material</p>
                    <p><div class="general-block">For information about availability, see the <i>Availability of Companion Documents</i> and <i>Patient Resources</i> fields below.</div></p>

            </div>
                <h2 id="439" class="accordion-title section-439 is-active" role="tab" aria-expanded="true"><a href="#">Institute of Medicine (IOM) National Healthcare Quality Report Categories</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">IOM Care Need</a></h3>
                    <p>Living with Illness</p>
                        <h3><a href="#">IOM Domain</a></h3>
                    <p>Effectiveness</p>
                    <p>Patient-centeredness</p>

            </div>
                <h2 id="442" class="accordion-title section-442 is-active" role="tab" aria-expanded="true"><a href="#">Identifying Information and Availability</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Bibliographic Source(s)</a></h3>
                    <p><table><tr><td>Preissner K. Occupational therapy practice guidelines for adults with neurodegenerative diseases. Bethesda (MD): American Occupational Therapy Association, Inc. (AOTA); 2014. 187 p.  [225 references]</td></tr></table></p>
                        <h3><a href="#">Adaptation</a></h3>
                    <p><div class="content_para"><p>Not applicable: The guideline was not adapted from another source.</p></div></p>
                        <h3><a href="#">Date Released</a></h3>
                    <p>2014</p>
                        <h3><a href="#">Guideline Developer(s)</a></h3>
                    <p>American Occupational Therapy Association, Inc. - Professional Association</p>
                        <h3><a href="#">Source(s) of Funding</a></h3>
                    <p><div class="content_para"><p>American Occupational Therapy Association, Inc.</p></div></p>
                        <h3><a href="#">Guideline Committee</a></h3>
                    <p><div class="content_para"><p>Not stated</p></div></p>
                        <h3><a href="#">Composition of Group That Authored the Guideline</a></h3>
                    <p><div class="content_para"><p><em>Author</em>: Katharine Preissner, EdD, OTR/L, Clinical Associate Professor and Academic Fieldwork Coordinator, Department of Occupational Therapy, College of Applied Health Sciences, University of Illinois at Chicago, Chicago</p>
<p><em>Series Editor</em>: Deborah Lieberman, MHSA, OTR/L, FAOTA, Director, Evidence-Based Practice, Staff Liaison to the Commission on Practice, American Occupational Therapy Association, Bethesda, MD</p>
<p><em>Issue Editor</em>: Marian Arbesman, PhD, OTR/L, President, ArbesIdeas, Inc., Consultant, AOTA Evidence-Based Practice Project, Clinical Assistant Professor, Department of Rehabilitation Science, State University of New York at Buffalo</p></div></p>
                        <h3><a href="#">Financial Disclosures/Conflicts of Interest</a></h3>
                    <p><div class="content_para"><p>The authors of this Practice Guideline have signed a Conflict of Interest statement indicating that they have no conflicts that would bear on this work.</p></div></p>
                        <h3><a href="#">Guideline Status</a></h3>
                    <p><div class="content_para"><p>This is the current release of the guideline.</p>
<p>This guideline meets NGC's 2013 (revised) inclusion criteria.</p></div></p>
                        <h3><a href="#">Guideline Availability</a></h3>
                    <p><div class="content_para"><p>Available for purchase from the <a href="/web/20180712210301/https://www.guideline.gov/Home/Disclaimer?id=48512&amp;contentType=summary&amp;redirect=https%3a%2f%2fmyaota.aota.org%2fshop_aota%2fprodview.aspx%3fPID%3d209452232%26SKU%3d900355%26TYPE%3dD" title="American Occupational Therapy Association (AOTA) Web site">American Occupational Therapy Association (AOTA) Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712210301im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>.</p></div></p>
                        <h3><a href="#">Availability of Companion Documents</a></h3>
                    <p><div class="content_para"><p>The following are available:</p>
<ul style="list-style-type: disc;">
    <li>Occupational therapy practice framework: domain and process. 3rd ed. (MD): American Occupational Therapy Association, Inc. (AOTA); 2014. Available for purchase from the <a href="/web/20180712210301/https://www.guideline.gov/Home/Disclaimer?id=48512&amp;contentType=summary&amp;redirect=http%3a%2f%2fmyaota.aota.org%2fshop_aota%2fprodview.aspx%3fTYPE%3dD%26PID%3d230090381%26SKU%3d900361" title="American Occupational Therapy Association (AOTA) Web site">American Occupational Therapy Association (AOTA) Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712210301im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>. </li>
    <li>The role of occupational therapy in chronic disease management. Fact sheet. Bethesda (MD): American Occupational Therapy Association, Inc. (AOTA). 4 p. Available from the <a href="/web/20180712210301/https://www.guideline.gov/Home/Disclaimer?id=48512&amp;contentType=summary&amp;redirect=https%3a%2f%2fwww.aota.org%2f%7e%2fmedia%2fCorporate%2fFiles%2fAboutOT%2fProfessionals%2fWhatIsOT%2fHW%2fFacts%2fFactSheet_ChronicDiseaseManagement.pdf" title="AOTA Web site">AOTA Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712210301im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>. </li>
</ul>
<p>In addition, case studies are available in the original guideline document.</p></div></p>
                        <h3><a href="#">Patient Resources</a></h3>
                    <p><div class="content_para"><p>None available</p></div></p>
                        <h3><a href="#">NGC Status</a></h3>
                    <p><div class="content_para"><p>This NGC summary was completed by ECRI Institute on October 10, 2014.</p></div></p>
                        <h3><a href="#">Copyright Statement</a></h3>
                    <p><div class="content_para"><p>This NGC summary is based on the original guideline, which is subject to the guideline developer's copyright restrictions.</p></div></p>

            </div>
                <h2 id="99999" class="accordion-title section-99999 is-active" role="tab" aria-expanded="true"><a href="#">Disclaimer</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">NGC Disclaimer</a></h3>
                    <p><p>The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.</p> 
<p>All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.</p> 
<p>Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the <a href="/web/20180712210301/https://www.guideline.gov/help-and-about/summaries/inclusion-criteria">NGC Inclusion Criteria</a>.</p> 
<p>NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.</p> 
<p>Readers with questions regarding guideline content are directed to contact the guideline developer.</p></p>

            </div>

    </div>
    <!-- /.accordion-container -->

<!-- ASIDE -->
<!-- FOOTER -->






		</div><!-- /.article -->

	</div><!-- /.content -->

	
			<div class="aside">
				

    <!-- About NGC -->
    <div class="info-block">
            <h3 class="info prefix-icon large-icon">About NGC Guideline Summaries</h3>
            <p>NGC provides structured summaries containing information from clinical practice guidelines.</p>
            <ul>
                <li><a href="/web/20180712210301/https://www.guideline.gov/help-and-about/summaries/inclusion-criteria" class="internal-link">Inclusion Criteria</a></li>
                <li><a href="/web/20180712210301/https://www.guideline.gov/help-and-about/summaries/template-of-guideline-attributes" class="internal-link">Template of Guideline Attributes</a></li>
                <li><a href="/web/20180712210301/https://www.guideline.gov/help-and-about/summaries/classification-scheme" class="internal-link">Classification Scheme</a></li>
            </ul>
            <p><a href="/web/20180712210301/https://www.guideline.gov/help-and-about/summaries/faqs" class="help-button">Guideline Summary FAQs</a></p>

    </div>
    <!-- /info-block -->

    <!-- Guideline Synthesis -->

    <!-- HHS Block -->

    <!-- Related Content -->


    <hr>

    <!-- New on NGC -->
    <div class="subscribe-header">
        <h3 class="subscribe-title">New on NGC</h3>
        <ul class="subscribe-links">
            <li><a href="/web/20180712210301/https://www.guideline.gov/subscribe" class="newsletter"><span class="subscribe-links-label">Get Email Alerts</span></a></li>
            <li><a href="/web/20180712210301/https://www.guideline.gov/rssFiles/ngc_newthisweek.xml" class="rss"><span class="subscribe-links-label">RSS Feed</span></a></li>
        </ul>
    </div>
    <!-- /.subscribe-header -->
        <h5 class="prefix-icon guideline news-list-category-label">Guideline Summaries</h5>
        <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011378</li>
            <li>2017 Oct</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712210301/https://www.guideline.gov/summaries/summary/51300/mental-health-care-in-the-perinatal-period-australian-clinical-practice-guideline">Mental health care in the perinatal period: Australian clinical practice guideline.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011372</li>
            <li>2015</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712210301/https://www.guideline.gov/summaries/summary/51294/clinical-practice-guideline-on-systemic-lupus-erythematosus">Clinical practice guideline on systemic lupus erythematosus.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011385</li>
            <li>2018 Mar</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712210301/https://www.guideline.gov/summaries/summary/51326/vadod-clinical-practice-guideline-for-the-management-of-pregnancy">VA/DoD clinical practice guideline for the management of pregnancy.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011376</li>
            <li>2018 Feb</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712210301/https://www.guideline.gov/summaries/summary/51298/clinical-pharmacogenetics-implementation-consortium-cpic-guideline-for-dihydropyrimidine-dehydrogenase-genotype-and-fluoropyrimidine-dosing-2017-update">Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing: 2017 update.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011370</li>
            <li>2017 Dec</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712210301/https://www.guideline.gov/summaries/summary/51292/the-implementation-of-targeted-temperature-management-an-evidencebased-guideline-from-the-neurocritical-care-society">The implementation of targeted temperature management: an evidence-based guideline from the Neurocritical Care Society.</a></p>
    </div>

    <a class="block-link" href="/web/20180712210301/https://www.guideline.gov/new-this-week/index">
        <h3>New This Week </h3>
        <p>View more and sign up for our Newsletter</p>
    </a>
    <!-- Adobe Reader -->
    <p><a href="/web/20180712210301/https://www.guideline.gov/disclaimer?id=48512&amp;contentType=summary&amp;redirect=http%3A%2F%2Fget.adobe.com%2Freader%2F" class="external-link">Get Adobe Reader</a></p>

			</div><!-- /.aside -->
		</div><!-- /.aside-container -->

	<!-- BACK TO TOP -->
	
	
	



    <!-- COMMENTS -->
    

</div><!-- /.main -->

	</main>

	<!-- FOOTER -->
	<div class="footer" id="footer">

		<div class="footer-grid-container">
			<!-- Header -->
			<div class="footer-header">
				<a href="#" class="footer-logo">
			 		<picture>
					  	<source type="image/svg+xml" srcset="/web/20180712210301im_/https://www.guideline.gov/UI/images/logo_NGC_footer.svg">
					  	<img src="/web/20180712210301im_/https://www.guideline.gov/UI/images/logo_NGC_footer.png" alt="NGC">
					</picture>
				</a>
			</div><!-- /.footer-header -->

			<!-- Content -->
			<div class="footer-content">
				<div class="footer-nav">
					<ul class="level-1">
						<li><a href="/web/20180712210301/https://www.guideline.gov/">Home</a></li>
		                <li><a href="/web/20180712210301/https://www.guideline.gov/new-this-week/index">New This Week</a></li>
						<li><a href="/web/20180712210301/https://www.guideline.gov/browse/organization" class="parent-link">Guideline Summaries</a></li>
<li><a href="/web/20180712210301/https://www.guideline.gov/syntheses/index">Guideline Syntheses</a></li>						<li><a href="/web/20180712210301/https://www.guideline.gov/expert">Expert Commentaries</a></li>
		                <li><a href="/web/20180712210301/https://www.guideline.gov/matrix">Matrix Tool</a></li>
						<li><a href="/web/20180712210301/https://www.guideline.gov/summaries/submit">Submit Guidelines</a></li>
						<li><a href="/web/20180712210301/https://www.guideline.gov/help-and-about">Help &amp;&nbsp;About</a></li>
					</ul>
					<ul class="level-2">
						<li><a href="/web/20180712210301/https://www.guideline.gov/contact-us">Contact Us</a></li>
						<li><a href="/web/20180712210301/https://www.guideline.gov/rss">RSS</a></li>
					    <li><a href="/web/20180712210301/https://www.guideline.gov/site-map">Site Map</a></li>
                        <li><a href="/web/20180712210301/https://www.guideline.gov/browse/related">Related NQMC Measures</a></li>
                        <li><a href="/web/20180712210301/https://www.guideline.gov/help-and-about/about/editorial-board">Editorial Board</a></li>
                        <li><a href="/web/20180712210301/https://www.guideline.gov/help-and-about/general/web-site-credits">Web Site Credits</a></li>
                        <li><a href="/web/20180712210301/https://www.guideline.gov/help-and-about/general/disclaimer">Disclaimer</a></li>
						<li><a href="/web/20180712210301/https://www.guideline.gov/help-and-about/general/privacy">Privacy Policy</a></li>
                        <li><a href="/web/20180712210301/https://www.guideline.gov/help-and-about/technical/accessibility">Accessibility</a></li>	
                        <li><a href="/web/20180712210301/https://www.guideline.gov/help-and-about/technical/for-web-developers">For Web Developers</a></li>
					</ul>
				</div><!-- /.footer-nav -->
			</div><!-- /.footer-content -->

			<!-- Aside -->
			<div class="footer-aside">
				<h5 class="footer-partner-link-header">Visit our partner sites</h5>
				<ul class="footer-partner-links">
				    <li><!-- NQMC footer link -->
						<a href="https://web.archive.org/web/20180712210301/https://www.qualitymeasures.ahrq.gov/" target="_blank" class="partner-button nqmc">
							<span class="partner-logo">
								<picture>
							    	<source type="image/svg+xml" srcset="/web/20180712210301im_/https://www.guideline.gov/UI/images/logo_footerlink_nqmc.svg">
									<img src="/web/20180712210301im_/https://www.guideline.gov/UI/images/logo_footerlink_nqmc.png" alt="National Quality Measures Clearinghouse"/>
								</picture>
							</span>
						</a>
					</li><!--/MQMC footer Link -->
					<li><!-- HHS footer link --> 
						<a href="https://web.archive.org/web/20180712210301/https://www.qualitymeasures.ahrq.gov/hhs/index.aspx" target="_blank" class="partner-button hhs">
							<span class="partner-logo">
								<picture>
								    <source type="image/svg+xml" srcset="/web/20180712210301im_/https://www.guideline.gov/UI/images/logo_footerlink_hmis.svg">
								    <img src="/web/20180712210301im_/https://www.guideline.gov/UI/images/logo_footerlink_hmis.png" alt="HHS Measures Inventory"/>
								</picture>
							</span>
						</a>
					</li><!--/HHS footer link -->
				</ul>
			</div><!-- /.footer-aside -->

		</div><!-- /.footer-grid-container -->

	</div><!-- /.footer -->

	
	<!-- AHRQ FOOTER -->
	<div id="ahrq-footer">

		<!-- FIRST -->
		<div class="ahrq-first-footer">
			<div class="column">
			<div class="ahrq-footer-grid-container">
				<div class="ahrq-footer-left">
					<p><a href="https://web.archive.org/web/20180712210301/http://www.ahrq.gov/index.html" class="ahrq-footer-logo" target="_blank">AHRQ</a></p>
				</div><!-- /.ahrq-footer-left -->
				<div class="ahrq-footer-center">
					<ul>
						<li><a href="https://web.archive.org/web/20180712210301/http://www.ahrq.gov/policy/electronic/accessibility/index.html" target="_blank">Accessibility</a></li>
						<li><a href="https://web.archive.org/web/20180712210301/http://www.ahrq.gov/policy/electronic/disclaimers/index.html" target="_blank">Disclaimers</a></li>
						<li><a href="https://web.archive.org/web/20180712210301/http://www.ahrq.gov/policy/eeo/index.html" target="_blank">EEO</a></li>
						<li><a href="https://web.archive.org/web/20180712210301/http://www.ahrq.gov/policy/foia/index.html" target="_blank">FOIA</a></li>
						<li><a href="https://web.archive.org/web/20180712210301/http://www.hhs.gov/web/governance/digital-strategy/index.html" target="_blank">HHS Digital Strategy</a></li>
						<li><a href="https://web.archive.org/web/20180712210301/http://oig.hhs.gov/" target="_blank">Inspector General</a></li>
						<li><a href="https://web.archive.org/web/20180712210301/http://www.ahrq.gov/policy/electronic/plain-writing/index.html" target="_blank">Plain Writing Act</a></li>
						<li><a href="https://web.archive.org/web/20180712210301/http://www.ahrq.gov/policy/electronic/privacy/index.html" target="_blank">Privacy Policy</a></li>
						<li><a href="https://web.archive.org/web/20180712210301/http://www.ahrq.gov/policy/electronic/about/policyix.html" target="_blank">Electronic Policies</a></li>
						<li><a href="https://web.archive.org/web/20180712210301/http://www.hhs.gov/plugins.html" target="_blank">Viewers &amp; Players</a></li>
					</ul>
				</div><!-- /.ahrq-footer-center -->
				<div class="ahrq-footer-right">
					<h3>Get Social</h3>
					<ul class="ahrq-social">
						<li><a href="https://web.archive.org/web/20180712210301/http://www.facebook.com/" target="_blank" class="facebook"><span class="screen-reader-text">Facebook</span></a></li>
						<li><a href="https://web.archive.org/web/20180712210301/http://www.twitter.com/" target="_blank" class="twitter"><span class="screen-reader-text">Twitter</span></a></li>
						<li><a href="https://web.archive.org/web/20180712210301/http://www.linkedin.com/" target="_blank" class="linkedin"><span class="screen-reader-text">LinkedIn</span></a></li>
						<li><a href="https://web.archive.org/web/20180712210301/http://www.youtube.com/" target="_blank" class="youtube"><span class="screen-reader-text">YouTube</span></a></li>
					</ul>
				</div><!-- /.ahrq-footer-right -->
			</div><!-- /.ahrq-footer-grid-container -->
			</div><!-- /.column -->
		</div><!-- /.first-footer -->

		<!-- SECOND -->
		<div class="ahrq-second-footer">
			<div class="column">
			<div class="ahrq-footer-grid-container">
				<div class="ahrq-footer-left">
					<ul>
						<li><a href="https://web.archive.org/web/20180712210301/http://www.ahrq.gov/index.html" target="_blank" class="ahrq-footer-home-link"><span class="screen-reader-text">AHRQ Home</span></a></li>
						<li><a href="https://web.archive.org/web/20180712210301/http://www.ahrq.gov/cpi/about/index.html" target="_blank">About Us</a></li>
						<li><a href="https://web.archive.org/web/20180712210301/http://www.ahrq.gov/cpi/about/careers/index.html" target="_blank">Careers</a></li>
						<li><a href="https://web.archive.org/web/20180712210301/http://www.ahrq.gov/contact/index.html" target="_blank">Contact Us</a></li>
						<li><a href="https://web.archive.org/web/20180712210301/http://www.ahrq.gov/Sitemap.html" target="_blank">Sitemap</a></li>
						<li><a href="https://web.archive.org/web/20180712210301/https://info.ahrq.gov/" target="_blank">FAQ</a></li>
					</ul>	
				</div><!-- /.ahrq-footer-left -->
				<div class="ahrq-footer-center">
					<ul>
						<li><a href="https://web.archive.org/web/20180712210301/http://www.ahrq.gov/health-care-information/index.html" target="_blank">Health Care Information</a></li>
						<li><a href="https://web.archive.org/web/20180712210301/http://www.ahrq.gov/patients-consumers/index.html" target="_blank">For Patients &amp; Consumers</a></li>
						<li><a href="https://web.archive.org/web/20180712210301/http://www.ahrq.gov/professionals/index.html" target="_blank">For Professionals</a></li>
						<li><a href="https://web.archive.org/web/20180712210301/http://www.ahrq.gov/policymakers/index.html" target="_blank">For Policymakers</a></li>
						<li><a href="https://web.archive.org/web/20180712210301/http://www.ahrq.gov/research/index.html" target="_blank">Research Tools &amp; Data</a></li>
						<li><a href="https://web.archive.org/web/20180712210301/http://www.ahrq.gov/funding/index.html" target="_blank">Funding &amp; Grants</a></li>
						<li><a href="https://web.archive.org/web/20180712210301/http://www.ahrq.gov/cpi/index.html" target="_blank">Offices, Centers &amp; Programs</a></li>
						<li><a href="https://web.archive.org/web/20180712210301/http://www.ahrq.gov/news/index.html" target="_blank">News &amp; Events</a></li>
					</ul>
				</div><!-- /.ahrq-footer-center -->
				<div class="ahrq-footer-right">
					<ul>
						<li><a href="https://web.archive.org/web/20180712210301/http://www.hhs.gov/" target="_blank">U.S. Department of Health &amp; Human Services</a></li>
						<li><a href="https://web.archive.org/web/20180712210301/http://www.whitehouse.gov/" target="_blank">The White House</a></li>
						<li><a href="https://web.archive.org/web/20180712210301/http://www.usa.gov/" target="_blank">USA.gov: The U.S. Government's Official Web Portal   </a></li>
					</ul>
					<p class="ahrq-address">
						<strong>Agency for Healthcare Research&nbsp;and&nbsp;Quality</strong>
					    <br/>5600 Fishers Lane
					    <br/>Rockville, MD 20857
					    <br/><strong>Telephone:</strong> (301) 427-1364
					</p>
				</div><!-- /.ahrq-footer-right -->
			</div><!-- /.ahrq-footer-grid-container -->
			</div><!-- /.column -->
		</div><!-- /.second-footer -->
	</div><!-- /#ahrq-footer -->


	
	<!-- SCRIPTS -->
	
<script src="//web.archive.org/web/20180712210301js_/https://ajax.googleapis.com/ajax/libs/jquery/1.6.3/jquery.min.js" type="text/javascript"></script>
<script type="text/javascript">
if(!window.jQuery){
document.write('<script src="/cassette.axd/script/cdd67f922f9d413eaccb759182297335f87c3ff7/UI/js/jquery.js" type="text/javascript"><\/script>');
}
</script>
<script src="/web/20180712210301js_/https://www.guideline.gov/cassette.axd/script/595952c286b7fd52f0737b6f62085709be93156a/bodyJS" type="text/javascript"></script>

    
</body>
</html>
<!--
     FILE ARCHIVED ON 21:03:01 Jul 12, 2018 AND RETRIEVED FROM THE
     INTERNET ARCHIVE ON 16:45:11 Jul 15, 2018.
     JAVASCRIPT APPENDED BY WAYBACK MACHINE, COPYRIGHT INTERNET ARCHIVE.

     ALL OTHER CONTENT MAY ALSO BE PROTECTED BY COPYRIGHT (17 U.S.C.
     SECTION 108(a)(3)).
-->
<!--
playback timings (ms):
  LoadShardBlock: 335.078 (3)
  esindex: 0.025
  captures_list: 402.586
  CDXLines.iter: 35.572 (3)
  PetaboxLoader3.datanode: 109.848 (4)
  exclusion.robots: 0.278
  exclusion.robots.policy: 0.259
  RedisCDXSource: 26.237
  PetaboxLoader3.resolve: 238.465 (2)
  load_resource: 42.723
-->